世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

エクソソーム迅速分子検出の世界市場インサイト、2030年までの予測


Global Exosome Rapid Molecular Detection Market Insights, Forecast to 2030

エクソソーム分子検出とは、エクソソームを分子レベルで同定、分離、分析するための方法と技術を指す。 市場分析と洞察エクソソーム迅速分子検出の世界市場 エクソソーム迅速分子検出の世界市場は、予測期間中... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2024年2月16日 US$3,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

エクソソーム分子検出とは、エクソソームを分子レベルで同定、分離、分析するための方法と技術を指す。
市場分析と洞察エクソソーム迅速分子検出の世界市場
エクソソーム迅速分子検出の世界市場は、予測期間中に年平均成長率(CAGR)%で、2024年の100万米ドルから2030年には100万米ドルに成長すると予測される。
エクソソーム迅速分子検出の米国とカナダ市場は、2025年から2030年の予測期間中に年平均成長率(CAGR)%で、2024年の百万米ドルから2030年には百万米ドルに達すると推定される。
エクソソーム迅速分子検出の中国市場は、2024年の100万ドルから2025年から2030年の予測期間中に年平均成長率(CAGR)%で増加し、2030年には100万ドルに達すると推定される。
エクソソーム迅速分子検出のヨーロッパ市場は、2024年の100万ドルから2025年から2030年の予測期間中に年平均成長率(CAGR)%で増加し、2030年には100万ドルに達すると推定される。

エクソソーム迅速分子検出の世界の主要企業には、Thermo Fisher Scientific、Bio-Techne、System Biosciences、QIAGEN、Lonza、NX Pharmagen、NanoSomiX、Miltenyi Biotech、Norgen Biotekなどがある。2023年、世界の上位5社の売上高シェアは約 %であった。
エクソソーム迅速分子検出は、癌、神経変性疾患、心血管疾患、感染症など様々な分野で広く使用されている。癌はエクソソーム迅速分子検出産業発展の最大の支えである。2023年、エクソソーム迅速分子検出の世界的な売上は、がんが占めており、その割合は2030年には%に達するだろう。

レポートの対象
本レポートは、エクソソーム迅速分子検出の世界市場規模の概要を紹介します。2019年~2023年の過去の市場収益データ、2024年の推定値、2030年までのCAGR予測による世界市場動向の分析。
本レポートでは、エクソソーム迅速分子検出の主要生産者を調査し、主要地域と国の収益も提供しています。エクソソーム迅速分子検出の今後の市場可能性のハイライトと、この市場を様々なセグメントとサブセグメントに予測するための主要地域/国の注目点。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データと市場価値分析。

本レポートでは、エクソソーム迅速分子検出の収益、市場シェア、主要企業の業界ランキングに焦点を当て、2019年から2024年までのデータを掲載しています。世界のエクソソーム迅速分子検出市場における主要な利害関係者を特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。
本レポートでは、2019年から2030年までのタイプ別、用途別のセグメントデータ、収益、成長率を分析しています。エクソソーム迅速分子検出の収益、予測成長動向、生産技術、用途、エンドユーザー産業の市場規模を評価・予測します。

市場区分
企業別
サーモフィッシャーサイエンティフィック
バイオテクネ
システムバイオサイエンス
QIAGEN
ロンザ
NXファーマゲン
ナノソミックス
ミルテニ・バイオテック

AMSBio社
、、生薬メーカー



ー クリエイティブ・メディカル・テクノロジーズ
、生薬
学院
リオン
生細胞誘導システム
、、生細胞誘導システム
ダナハー
エクソファーム
エバーゾム
ルースター・バイオ
クリエイティブ・バイオラボ
タイプ別セグメント
キット・試薬
器具
サービス
アプリケーション別

神経変性疾患
心血管疾患
感染症
その他
地域別
北米
米国
カナダ
欧州
ドイツ
フランス
英国
イタリア
ロシア
北欧諸国
その他の欧州諸国
中国
アジア(中国を除く)
日本
韓国
中国 台湾
東南アジア
インド
ラテンアメリカ、中東、アフリカ
ブラジル
メキシコ
トルコ
イスラエル
GCC諸国

各章の概要
第1章:報告書のスコープ、各市場セグメント(製品タイプ、用途など)の市場規模、将来の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と短期・中期・長期的な展開の可能性を高いレベルで展望しています。
第2章 エクソソーム迅速分子検出の世界・地域レベルでの収益各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、生産能力などを紹介しています。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界各社が直面する課題とリスク、業界の関連政策の分析などを紹介します。
第3章:エクソソーム迅速分子検出企業の競争環境、収益、市場シェア、業界ランキング、最新の開発計画、合併・買収情報などを詳細に分析。
第4章:各種市場セグメントをタイプ別に分析し、各市場セグメントの収益、発展の可能性を網羅し、読者が各市場セグメントのブルーオーシャン市場を見つけるのに役立つ。
第5章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの収益、発展の可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。
第6章:北米(米国・カナダ):タイプ別、用途別、国別、セグメント別の収益。
第7章:ヨーロッパ:タイプ別、用途別、国別、セグメント別収益。
第8章:中国:タイプ別、用途別、セグメント別収益。
第9章:アジア(中国を除く):タイプ別、用途別、地域別、各セグメントの収益。
第10章:中東、アフリカ、ラテンアメリカ:タイプ別、用途別、国別、セグメント別収益。
第11章:主要企業のプロファイルを提供し、製品の説明や仕様、エクソソーム迅速分子検出の収益、売上総利益率、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介する。
第12章 アナリストの視点/結論


ページTOPに戻る


目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Rapid Molecular Detection Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Kits & Reagents
1.2.3 Instruments
1.2.4 Services
1.3 Market by Application
1.3.1 Global Exosome Rapid Molecular Detection Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Cancers
1.3.3 Neurodegenerative Diseases
1.3.4 Cardiovascular Diseases
1.3.5 Infectious Diseases
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exosome Rapid Molecular Detection Market Perspective (2019-2030)
2.2 Global Exosome Rapid Molecular Detection Growth Trends by Region
2.2.1 Exosome Rapid Molecular Detection Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Exosome Rapid Molecular Detection Historic Market Size by Region (2019-2024)
2.2.3 Exosome Rapid Molecular Detection Forecasted Market Size by Region (2025-2030)
2.3 Exosome Rapid Molecular Detection Market Dynamics
2.3.1 Exosome Rapid Molecular Detection Industry Trends
2.3.2 Exosome Rapid Molecular Detection Market Drivers
2.3.3 Exosome Rapid Molecular Detection Market Challenges
2.3.4 Exosome Rapid Molecular Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Exosome Rapid Molecular Detection by Players
3.1.1 Global Exosome Rapid Molecular Detection Revenue by Players (2019-2024)
3.1.2 Global Exosome Rapid Molecular Detection Revenue Market Share by Players (2019-2024)
3.2 Global Exosome Rapid Molecular Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Exosome Rapid Molecular Detection, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Exosome Rapid Molecular Detection Market Concentration Ratio
3.4.1 Global Exosome Rapid Molecular Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Rapid Molecular Detection Revenue in 2023
3.5 Global Key Players of Exosome Rapid Molecular Detection Head office and Area Served
3.6 Global Key Players of Exosome Rapid Molecular Detection, Product and Application
3.7 Global Key Players of Exosome Rapid Molecular Detection, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosome Rapid Molecular Detection Breakdown Data by Type
4.1 Global Exosome Rapid Molecular Detection Historic Market Size by Type (2019-2024)
4.2 Global Exosome Rapid Molecular Detection Forecasted Market Size by Type (2025-2030)
5 Exosome Rapid Molecular Detection Breakdown Data by Application
5.1 Global Exosome Rapid Molecular Detection Historic Market Size by Application (2019-2024)
5.2 Global Exosome Rapid Molecular Detection Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Exosome Rapid Molecular Detection Market Size (2019-2030)
6.2 North America Exosome Rapid Molecular Detection Market Size by Type
6.2.1 North America Exosome Rapid Molecular Detection Market Size by Type (2019-2024)
6.2.2 North America Exosome Rapid Molecular Detection Market Size by Type (2025-2030)
6.2.3 North America Exosome Rapid Molecular Detection Market Share by Type (2019-2030)
6.3 North America Exosome Rapid Molecular Detection Market Size by Application
6.3.1 North America Exosome Rapid Molecular Detection Market Size by Application (2019-2024)
6.3.2 North America Exosome Rapid Molecular Detection Market Size by Application (2025-2030)
6.3.3 North America Exosome Rapid Molecular Detection Market Share by Application (2019-2030)
6.4 North America Exosome Rapid Molecular Detection Market Size by Country
6.4.1 North America Exosome Rapid Molecular Detection Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Exosome Rapid Molecular Detection Market Size by Country (2019-2024)
6.4.3 North America Exosome Rapid Molecular Detection Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Exosome Rapid Molecular Detection Market Size (2019-2030)
7.2 Europe Exosome Rapid Molecular Detection Market Size by Type
7.2.1 Europe Exosome Rapid Molecular Detection Market Size by Type (2019-2024)
7.2.2 Europe Exosome Rapid Molecular Detection Market Size by Type (2025-2030)
7.2.3 Europe Exosome Rapid Molecular Detection Market Share by Type (2019-2030)
7.3 Europe Exosome Rapid Molecular Detection Market Size by Application
7.3.1 Europe Exosome Rapid Molecular Detection Market Size by Application (2019-2024)
7.3.2 Europe Exosome Rapid Molecular Detection Market Size by Application (2025-2030)
7.3.3 Europe Exosome Rapid Molecular Detection Market Share by Application (2019-2030)
7.4 Europe Exosome Rapid Molecular Detection Market Size by Country
7.4.1 Europe Exosome Rapid Molecular Detection Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Exosome Rapid Molecular Detection Market Size by Country (2019-2024)
7.4.3 Europe Exosome Rapid Molecular Detection Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Exosome Rapid Molecular Detection Market Size (2019-2030)
8.2 China Exosome Rapid Molecular Detection Market Size by Type
8.2.1 China Exosome Rapid Molecular Detection Market Size by Type (2019-2024)
8.2.2 China Exosome Rapid Molecular Detection Market Size by Type (2025-2030)
8.2.3 China Exosome Rapid Molecular Detection Market Share by Type (2019-2030)
8.3 China Exosome Rapid Molecular Detection Market Size by Application
8.3.1 China Exosome Rapid Molecular Detection Market Size by Application (2019-2024)
8.3.2 China Exosome Rapid Molecular Detection Market Size by Application (2025-2030)
8.3.3 China Exosome Rapid Molecular Detection Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Exosome Rapid Molecular Detection Market Size (2019-2030)
9.2 Asia Exosome Rapid Molecular Detection Market Size by Type
9.2.1 Asia Exosome Rapid Molecular Detection Market Size by Type (2019-2024)
9.2.2 Asia Exosome Rapid Molecular Detection Market Size by Type (2025-2030)
9.2.3 Asia Exosome Rapid Molecular Detection Market Share by Type (2019-2030)
9.3 Asia Exosome Rapid Molecular Detection Market Size by Application
9.3.1 Asia Exosome Rapid Molecular Detection Market Size by Application (2019-2024)
9.3.2 Asia Exosome Rapid Molecular Detection Market Size by Application (2025-2030)
9.3.3 Asia Exosome Rapid Molecular Detection Market Share by Application (2019-2030)
9.4 Asia Exosome Rapid Molecular Detection Market Size by Region
9.4.1 Asia Exosome Rapid Molecular Detection Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Exosome Rapid Molecular Detection Market Size by Region (2019-2024)
9.4.3 Asia Exosome Rapid Molecular Detection Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Size by Type
10.2.1 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Size by Application
10.3.1 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Size by Country
10.4.1 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Exosome Rapid Molecular Detection Introduction
11.1.4 Thermo Fisher Scientific Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Bio-Techne
11.2.1 Bio-Techne Company Details
11.2.2 Bio-Techne Business Overview
11.2.3 Bio-Techne Exosome Rapid Molecular Detection Introduction
11.2.4 Bio-Techne Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.2.5 Bio-Techne Recent Developments
11.3 System Biosciences
11.3.1 System Biosciences Company Details
11.3.2 System Biosciences Business Overview
11.3.3 System Biosciences Exosome Rapid Molecular Detection Introduction
11.3.4 System Biosciences Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.3.5 System Biosciences Recent Developments
11.4 QIAGEN
11.4.1 QIAGEN Company Details
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Exosome Rapid Molecular Detection Introduction
11.4.4 QIAGEN Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.4.5 QIAGEN Recent Developments
11.5 Lonza
11.5.1 Lonza Company Details
11.5.2 Lonza Business Overview
11.5.3 Lonza Exosome Rapid Molecular Detection Introduction
11.5.4 Lonza Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.5.5 Lonza Recent Developments
11.6 NX Pharmagen
11.6.1 NX Pharmagen Company Details
11.6.2 NX Pharmagen Business Overview
11.6.3 NX Pharmagen Exosome Rapid Molecular Detection Introduction
11.6.4 NX Pharmagen Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.6.5 NX Pharmagen Recent Developments
11.7 NanoSomiX
11.7.1 NanoSomiX Company Details
11.7.2 NanoSomiX Business Overview
11.7.3 NanoSomiX Exosome Rapid Molecular Detection Introduction
11.7.4 NanoSomiX Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.7.5 NanoSomiX Recent Developments
11.8 Miltenyi Biotech
11.8.1 Miltenyi Biotech Company Details
11.8.2 Miltenyi Biotech Business Overview
11.8.3 Miltenyi Biotech Exosome Rapid Molecular Detection Introduction
11.8.4 Miltenyi Biotech Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.8.5 Miltenyi Biotech Recent Developments
11.9 Norgen Biotek
11.9.1 Norgen Biotek Company Details
11.9.2 Norgen Biotek Business Overview
11.9.3 Norgen Biotek Exosome Rapid Molecular Detection Introduction
11.9.4 Norgen Biotek Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.9.5 Norgen Biotek Recent Developments
11.10 AMSBio
11.10.1 AMSBio Company Details
11.10.2 AMSBio Business Overview
11.10.3 AMSBio Exosome Rapid Molecular Detection Introduction
11.10.4 AMSBio Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.10.5 AMSBio Recent Developments
11.11 Aethlon Medical
11.11.1 Aethlon Medical Company Details
11.11.2 Aethlon Medical Business Overview
11.11.3 Aethlon Medical Exosome Rapid Molecular Detection Introduction
11.11.4 Aethlon Medical Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.11.5 Aethlon Medical Recent Developments
11.12 Anjarium Biosciences
11.12.1 Anjarium Biosciences Company Details
11.12.2 Anjarium Biosciences Business Overview
11.12.3 Anjarium Biosciences Exosome Rapid Molecular Detection Introduction
11.12.4 Anjarium Biosciences Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.12.5 Anjarium Biosciences Recent Developments
11.13 Ciloa
11.13.1 Ciloa Company Details
11.13.2 Ciloa Business Overview
11.13.3 Ciloa Exosome Rapid Molecular Detection Introduction
11.13.4 Ciloa Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.13.5 Ciloa Recent Developments
11.14 InnovaPrep
11.14.1 InnovaPrep Company Details
11.14.2 InnovaPrep Business Overview
11.14.3 InnovaPrep Exosome Rapid Molecular Detection Introduction
11.14.4 InnovaPrep Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.14.5 InnovaPrep Recent Developments
11.15 Creative Medical Technologies
11.15.1 Creative Medical Technologies Company Details
11.15.2 Creative Medical Technologies Business Overview
11.15.3 Creative Medical Technologies Exosome Rapid Molecular Detection Introduction
11.15.4 Creative Medical Technologies Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.15.5 Creative Medical Technologies Recent Developments
11.16 ILIAS Biologics
11.16.1 ILIAS Biologics Company Details
11.16.2 ILIAS Biologics Business Overview
11.16.3 ILIAS Biologics Exosome Rapid Molecular Detection Introduction
11.16.4 ILIAS Biologics Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.16.5 ILIAS Biologics Recent Developments
11.17 Unchained Labs
11.17.1 Unchained Labs Company Details
11.17.2 Unchained Labs Business Overview
11.17.3 Unchained Labs Exosome Rapid Molecular Detection Introduction
11.17.4 Unchained Labs Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.17.5 Unchained Labs Recent Developments
11.18 Rion
11.18.1 Rion Company Details
11.18.2 Rion Business Overview
11.18.3 Rion Exosome Rapid Molecular Detection Introduction
11.18.4 Rion Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.18.5 Rion Recent Developments
11.19 Cell Guidance System
11.19.1 Cell Guidance System Company Details
11.19.2 Cell Guidance System Business Overview
11.19.3 Cell Guidance System Exosome Rapid Molecular Detection Introduction
11.19.4 Cell Guidance System Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.19.5 Cell Guidance System Recent Developments
11.20 INOVIQ
11.20.1 INOVIQ Company Details
11.20.2 INOVIQ Business Overview
11.20.3 INOVIQ Exosome Rapid Molecular Detection Introduction
11.20.4 INOVIQ Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.20.5 INOVIQ Recent Developments
11.21 Danaher
11.21.1 Danaher Company Details
11.21.2 Danaher Business Overview
11.21.3 Danaher Exosome Rapid Molecular Detection Introduction
11.21.4 Danaher Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.21.5 Danaher Recent Developments
11.22 Exopharm
11.22.1 Exopharm Company Details
11.22.2 Exopharm Business Overview
11.22.3 Exopharm Exosome Rapid Molecular Detection Introduction
11.22.4 Exopharm Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.22.5 Exopharm Recent Developments
11.23 Everzom
11.23.1 Everzom Company Details
11.23.2 Everzom Business Overview
11.23.3 Everzom Exosome Rapid Molecular Detection Introduction
11.23.4 Everzom Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.23.5 Everzom Recent Developments
11.24 RoosterBio
11.24.1 RoosterBio Company Details
11.24.2 RoosterBio Business Overview
11.24.3 RoosterBio Exosome Rapid Molecular Detection Introduction
11.24.4 RoosterBio Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.24.5 RoosterBio Recent Developments
11.25 Creative Biolabs
11.25.1 Creative Biolabs Company Details
11.25.2 Creative Biolabs Business Overview
11.25.3 Creative Biolabs Exosome Rapid Molecular Detection Introduction
11.25.4 Creative Biolabs Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.25.5 Creative Biolabs Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る


 

Summary

Exosome molecular detection refers to methods and technologies used to identify, isolate, and analyze exosomes at the molecular level.
Market Analysis and Insights: Global Exosome Rapid Molecular Detection Market
The global Exosome Rapid Molecular Detection market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Exosome Rapid Molecular Detection is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Exosome Rapid Molecular Detection is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Exosome Rapid Molecular Detection is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Exosome Rapid Molecular Detection include Thermo Fisher Scientific, Bio-Techne, System Biosciences, QIAGEN, Lonza, NX Pharmagen, NanoSomiX, Miltenyi Biotech and Norgen Biotek, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Exosome Rapid Molecular Detection is widely used in various fields, such as Cancers, Neurodegenerative Diseases, Cardiovascular Diseases and Infectious Diseases, etc. Cancers provides greatest supports to the Exosome Rapid Molecular Detection industry development. In 2023, global % revenue of Exosome Rapid Molecular Detection went into Cancers filed and the proportion will reach to % in 2030.

Report Covers:
This report presents an overview of global market for Exosome Rapid Molecular Detection market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Exosome Rapid Molecular Detection, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Exosome Rapid Molecular Detection, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Exosome Rapid Molecular Detection revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Exosome Rapid Molecular Detection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Exosome Rapid Molecular Detection revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation
By Company
Thermo Fisher Scientific
Bio-Techne
System Biosciences
QIAGEN
Lonza
NX Pharmagen
NanoSomiX
Miltenyi Biotech
Norgen Biotek
AMSBio
Aethlon Medical
Anjarium Biosciences
Ciloa
InnovaPrep
Creative Medical Technologies
ILIAS Biologics
Unchained Labs
Rion
Cell Guidance System
INOVIQ
Danaher
Exopharm
Everzom
RoosterBio
Creative Biolabs
Segment by Type
Kits & Reagents
Instruments
Services
Segment by Application
Cancers
Neurodegenerative Diseases
Cardiovascular Diseases
Infectious Diseases
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Exosome Rapid Molecular Detection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exosome Rapid Molecular Detection companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Exosome Rapid Molecular Detection revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions



ページTOPに戻る


Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Rapid Molecular Detection Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Kits & Reagents
1.2.3 Instruments
1.2.4 Services
1.3 Market by Application
1.3.1 Global Exosome Rapid Molecular Detection Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Cancers
1.3.3 Neurodegenerative Diseases
1.3.4 Cardiovascular Diseases
1.3.5 Infectious Diseases
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exosome Rapid Molecular Detection Market Perspective (2019-2030)
2.2 Global Exosome Rapid Molecular Detection Growth Trends by Region
2.2.1 Exosome Rapid Molecular Detection Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Exosome Rapid Molecular Detection Historic Market Size by Region (2019-2024)
2.2.3 Exosome Rapid Molecular Detection Forecasted Market Size by Region (2025-2030)
2.3 Exosome Rapid Molecular Detection Market Dynamics
2.3.1 Exosome Rapid Molecular Detection Industry Trends
2.3.2 Exosome Rapid Molecular Detection Market Drivers
2.3.3 Exosome Rapid Molecular Detection Market Challenges
2.3.4 Exosome Rapid Molecular Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Exosome Rapid Molecular Detection by Players
3.1.1 Global Exosome Rapid Molecular Detection Revenue by Players (2019-2024)
3.1.2 Global Exosome Rapid Molecular Detection Revenue Market Share by Players (2019-2024)
3.2 Global Exosome Rapid Molecular Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Exosome Rapid Molecular Detection, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Exosome Rapid Molecular Detection Market Concentration Ratio
3.4.1 Global Exosome Rapid Molecular Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Rapid Molecular Detection Revenue in 2023
3.5 Global Key Players of Exosome Rapid Molecular Detection Head office and Area Served
3.6 Global Key Players of Exosome Rapid Molecular Detection, Product and Application
3.7 Global Key Players of Exosome Rapid Molecular Detection, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosome Rapid Molecular Detection Breakdown Data by Type
4.1 Global Exosome Rapid Molecular Detection Historic Market Size by Type (2019-2024)
4.2 Global Exosome Rapid Molecular Detection Forecasted Market Size by Type (2025-2030)
5 Exosome Rapid Molecular Detection Breakdown Data by Application
5.1 Global Exosome Rapid Molecular Detection Historic Market Size by Application (2019-2024)
5.2 Global Exosome Rapid Molecular Detection Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Exosome Rapid Molecular Detection Market Size (2019-2030)
6.2 North America Exosome Rapid Molecular Detection Market Size by Type
6.2.1 North America Exosome Rapid Molecular Detection Market Size by Type (2019-2024)
6.2.2 North America Exosome Rapid Molecular Detection Market Size by Type (2025-2030)
6.2.3 North America Exosome Rapid Molecular Detection Market Share by Type (2019-2030)
6.3 North America Exosome Rapid Molecular Detection Market Size by Application
6.3.1 North America Exosome Rapid Molecular Detection Market Size by Application (2019-2024)
6.3.2 North America Exosome Rapid Molecular Detection Market Size by Application (2025-2030)
6.3.3 North America Exosome Rapid Molecular Detection Market Share by Application (2019-2030)
6.4 North America Exosome Rapid Molecular Detection Market Size by Country
6.4.1 North America Exosome Rapid Molecular Detection Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Exosome Rapid Molecular Detection Market Size by Country (2019-2024)
6.4.3 North America Exosome Rapid Molecular Detection Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Exosome Rapid Molecular Detection Market Size (2019-2030)
7.2 Europe Exosome Rapid Molecular Detection Market Size by Type
7.2.1 Europe Exosome Rapid Molecular Detection Market Size by Type (2019-2024)
7.2.2 Europe Exosome Rapid Molecular Detection Market Size by Type (2025-2030)
7.2.3 Europe Exosome Rapid Molecular Detection Market Share by Type (2019-2030)
7.3 Europe Exosome Rapid Molecular Detection Market Size by Application
7.3.1 Europe Exosome Rapid Molecular Detection Market Size by Application (2019-2024)
7.3.2 Europe Exosome Rapid Molecular Detection Market Size by Application (2025-2030)
7.3.3 Europe Exosome Rapid Molecular Detection Market Share by Application (2019-2030)
7.4 Europe Exosome Rapid Molecular Detection Market Size by Country
7.4.1 Europe Exosome Rapid Molecular Detection Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Exosome Rapid Molecular Detection Market Size by Country (2019-2024)
7.4.3 Europe Exosome Rapid Molecular Detection Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Exosome Rapid Molecular Detection Market Size (2019-2030)
8.2 China Exosome Rapid Molecular Detection Market Size by Type
8.2.1 China Exosome Rapid Molecular Detection Market Size by Type (2019-2024)
8.2.2 China Exosome Rapid Molecular Detection Market Size by Type (2025-2030)
8.2.3 China Exosome Rapid Molecular Detection Market Share by Type (2019-2030)
8.3 China Exosome Rapid Molecular Detection Market Size by Application
8.3.1 China Exosome Rapid Molecular Detection Market Size by Application (2019-2024)
8.3.2 China Exosome Rapid Molecular Detection Market Size by Application (2025-2030)
8.3.3 China Exosome Rapid Molecular Detection Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Exosome Rapid Molecular Detection Market Size (2019-2030)
9.2 Asia Exosome Rapid Molecular Detection Market Size by Type
9.2.1 Asia Exosome Rapid Molecular Detection Market Size by Type (2019-2024)
9.2.2 Asia Exosome Rapid Molecular Detection Market Size by Type (2025-2030)
9.2.3 Asia Exosome Rapid Molecular Detection Market Share by Type (2019-2030)
9.3 Asia Exosome Rapid Molecular Detection Market Size by Application
9.3.1 Asia Exosome Rapid Molecular Detection Market Size by Application (2019-2024)
9.3.2 Asia Exosome Rapid Molecular Detection Market Size by Application (2025-2030)
9.3.3 Asia Exosome Rapid Molecular Detection Market Share by Application (2019-2030)
9.4 Asia Exosome Rapid Molecular Detection Market Size by Region
9.4.1 Asia Exosome Rapid Molecular Detection Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Exosome Rapid Molecular Detection Market Size by Region (2019-2024)
9.4.3 Asia Exosome Rapid Molecular Detection Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Size by Type
10.2.1 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Size by Application
10.3.1 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Size by Country
10.4.1 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Exosome Rapid Molecular Detection Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Exosome Rapid Molecular Detection Introduction
11.1.4 Thermo Fisher Scientific Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Bio-Techne
11.2.1 Bio-Techne Company Details
11.2.2 Bio-Techne Business Overview
11.2.3 Bio-Techne Exosome Rapid Molecular Detection Introduction
11.2.4 Bio-Techne Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.2.5 Bio-Techne Recent Developments
11.3 System Biosciences
11.3.1 System Biosciences Company Details
11.3.2 System Biosciences Business Overview
11.3.3 System Biosciences Exosome Rapid Molecular Detection Introduction
11.3.4 System Biosciences Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.3.5 System Biosciences Recent Developments
11.4 QIAGEN
11.4.1 QIAGEN Company Details
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Exosome Rapid Molecular Detection Introduction
11.4.4 QIAGEN Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.4.5 QIAGEN Recent Developments
11.5 Lonza
11.5.1 Lonza Company Details
11.5.2 Lonza Business Overview
11.5.3 Lonza Exosome Rapid Molecular Detection Introduction
11.5.4 Lonza Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.5.5 Lonza Recent Developments
11.6 NX Pharmagen
11.6.1 NX Pharmagen Company Details
11.6.2 NX Pharmagen Business Overview
11.6.3 NX Pharmagen Exosome Rapid Molecular Detection Introduction
11.6.4 NX Pharmagen Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.6.5 NX Pharmagen Recent Developments
11.7 NanoSomiX
11.7.1 NanoSomiX Company Details
11.7.2 NanoSomiX Business Overview
11.7.3 NanoSomiX Exosome Rapid Molecular Detection Introduction
11.7.4 NanoSomiX Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.7.5 NanoSomiX Recent Developments
11.8 Miltenyi Biotech
11.8.1 Miltenyi Biotech Company Details
11.8.2 Miltenyi Biotech Business Overview
11.8.3 Miltenyi Biotech Exosome Rapid Molecular Detection Introduction
11.8.4 Miltenyi Biotech Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.8.5 Miltenyi Biotech Recent Developments
11.9 Norgen Biotek
11.9.1 Norgen Biotek Company Details
11.9.2 Norgen Biotek Business Overview
11.9.3 Norgen Biotek Exosome Rapid Molecular Detection Introduction
11.9.4 Norgen Biotek Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.9.5 Norgen Biotek Recent Developments
11.10 AMSBio
11.10.1 AMSBio Company Details
11.10.2 AMSBio Business Overview
11.10.3 AMSBio Exosome Rapid Molecular Detection Introduction
11.10.4 AMSBio Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.10.5 AMSBio Recent Developments
11.11 Aethlon Medical
11.11.1 Aethlon Medical Company Details
11.11.2 Aethlon Medical Business Overview
11.11.3 Aethlon Medical Exosome Rapid Molecular Detection Introduction
11.11.4 Aethlon Medical Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.11.5 Aethlon Medical Recent Developments
11.12 Anjarium Biosciences
11.12.1 Anjarium Biosciences Company Details
11.12.2 Anjarium Biosciences Business Overview
11.12.3 Anjarium Biosciences Exosome Rapid Molecular Detection Introduction
11.12.4 Anjarium Biosciences Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.12.5 Anjarium Biosciences Recent Developments
11.13 Ciloa
11.13.1 Ciloa Company Details
11.13.2 Ciloa Business Overview
11.13.3 Ciloa Exosome Rapid Molecular Detection Introduction
11.13.4 Ciloa Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.13.5 Ciloa Recent Developments
11.14 InnovaPrep
11.14.1 InnovaPrep Company Details
11.14.2 InnovaPrep Business Overview
11.14.3 InnovaPrep Exosome Rapid Molecular Detection Introduction
11.14.4 InnovaPrep Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.14.5 InnovaPrep Recent Developments
11.15 Creative Medical Technologies
11.15.1 Creative Medical Technologies Company Details
11.15.2 Creative Medical Technologies Business Overview
11.15.3 Creative Medical Technologies Exosome Rapid Molecular Detection Introduction
11.15.4 Creative Medical Technologies Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.15.5 Creative Medical Technologies Recent Developments
11.16 ILIAS Biologics
11.16.1 ILIAS Biologics Company Details
11.16.2 ILIAS Biologics Business Overview
11.16.3 ILIAS Biologics Exosome Rapid Molecular Detection Introduction
11.16.4 ILIAS Biologics Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.16.5 ILIAS Biologics Recent Developments
11.17 Unchained Labs
11.17.1 Unchained Labs Company Details
11.17.2 Unchained Labs Business Overview
11.17.3 Unchained Labs Exosome Rapid Molecular Detection Introduction
11.17.4 Unchained Labs Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.17.5 Unchained Labs Recent Developments
11.18 Rion
11.18.1 Rion Company Details
11.18.2 Rion Business Overview
11.18.3 Rion Exosome Rapid Molecular Detection Introduction
11.18.4 Rion Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.18.5 Rion Recent Developments
11.19 Cell Guidance System
11.19.1 Cell Guidance System Company Details
11.19.2 Cell Guidance System Business Overview
11.19.3 Cell Guidance System Exosome Rapid Molecular Detection Introduction
11.19.4 Cell Guidance System Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.19.5 Cell Guidance System Recent Developments
11.20 INOVIQ
11.20.1 INOVIQ Company Details
11.20.2 INOVIQ Business Overview
11.20.3 INOVIQ Exosome Rapid Molecular Detection Introduction
11.20.4 INOVIQ Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.20.5 INOVIQ Recent Developments
11.21 Danaher
11.21.1 Danaher Company Details
11.21.2 Danaher Business Overview
11.21.3 Danaher Exosome Rapid Molecular Detection Introduction
11.21.4 Danaher Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.21.5 Danaher Recent Developments
11.22 Exopharm
11.22.1 Exopharm Company Details
11.22.2 Exopharm Business Overview
11.22.3 Exopharm Exosome Rapid Molecular Detection Introduction
11.22.4 Exopharm Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.22.5 Exopharm Recent Developments
11.23 Everzom
11.23.1 Everzom Company Details
11.23.2 Everzom Business Overview
11.23.3 Everzom Exosome Rapid Molecular Detection Introduction
11.23.4 Everzom Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.23.5 Everzom Recent Developments
11.24 RoosterBio
11.24.1 RoosterBio Company Details
11.24.2 RoosterBio Business Overview
11.24.3 RoosterBio Exosome Rapid Molecular Detection Introduction
11.24.4 RoosterBio Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.24.5 RoosterBio Recent Developments
11.25 Creative Biolabs
11.25.1 Creative Biolabs Company Details
11.25.2 Creative Biolabs Business Overview
11.25.3 Creative Biolabs Exosome Rapid Molecular Detection Introduction
11.25.4 Creative Biolabs Revenue in Exosome Rapid Molecular Detection Business (2019-2024)
11.25.5 Creative Biolabs Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療機器)の最新刊レポート

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る